High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

NCT06492759 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
29
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Emory University

Collaborators